US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist
  • 1.260
  • +0.030+2.44%
Close Nov 29 13:00 ET
  • 1.260
  • 0.0000.00%
Post 17:01 ET
44.05MMarket Cap-453P/E (TTM)

RAPT Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
-59.95%1.53M
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-59.95%1.53M
--0
Cost of revenue
Gross profit
Operating expense
-41.66%19.79M
3.41%29.33M
3.03%32.52M
45.51%127.06M
35.96%33.22M
56.47%33.92M
43.29%28.36M
47.36%31.56M
19.58%87.32M
30.02%24.43M
Selling and administrative expenses
-6.51%6.45M
-0.48%6.69M
29.21%7.74M
28.75%26.06M
29.66%6.45M
35.79%6.9M
23.66%6.72M
26.12%5.99M
26.21%20.24M
10.82%4.98M
-General and administrative expense
-6.51%6.45M
-0.48%6.69M
29.21%7.74M
28.75%26.06M
29.66%6.45M
35.79%6.9M
23.66%6.72M
26.12%5.99M
26.21%20.24M
10.82%4.98M
Research and development costs
-50.63%13.34M
4.61%22.64M
-3.10%24.78M
50.56%101M
37.58%26.76M
62.79%27.02M
50.72%21.64M
53.41%25.57M
17.72%67.08M
36.05%19.45M
Operating profit
41.66%-19.79M
-3.41%-29.33M
-3.03%-32.52M
-48.10%-127.06M
-35.96%-33.22M
-56.47%-33.92M
-50.00%-28.36M
-51.91%-31.56M
-23.97%-85.8M
-35.47%-24.43M
Net non-operating interest income expense
Other net income (expense)
-46.78%1.36M
-45.95%1.67M
-12.83%2M
424.48%10.26M
58.18%2.34M
475.17%2.55M
1,221.45%3.08M
641.42%2.29M
39,040.00%1.96M
1,309.52%1.48M
Other non- operating income (expenses)
-46.78%1.36M
-45.95%1.67M
-12.83%2M
424.48%10.26M
58.18%2.34M
475.17%2.55M
1,221.45%3.08M
641.42%2.29M
39,040.00%1.96M
1,309.52%1.48M
Income before tax
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
Income tax
Net income
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
Net income continuous Operations
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
Minority interest income
Net income attributable to the parent company
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
Basic earnings per share
42.68%-0.47
-7.58%-0.71
-3.95%-0.79
-18.22%-3.05
-26.56%-0.81
-30.16%-0.82
-6.45%-0.66
-10.14%-0.76
-1.98%-2.58
-4.92%-0.64
Diluted earnings per share
42.68%-0.47
-7.58%-0.71
-3.95%-0.79
-18.22%-3.05
-26.56%-0.81
-30.16%-0.82
-6.45%-0.66
-10.14%-0.76
-1.98%-2.58
-4.92%-0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 00000000-59.95%1.53M0
Operating revenue --0--0--0--0--0--0--0--0-59.95%1.53M--0
Cost of revenue
Gross profit
Operating expense -41.66%19.79M3.41%29.33M3.03%32.52M45.51%127.06M35.96%33.22M56.47%33.92M43.29%28.36M47.36%31.56M19.58%87.32M30.02%24.43M
Selling and administrative expenses -6.51%6.45M-0.48%6.69M29.21%7.74M28.75%26.06M29.66%6.45M35.79%6.9M23.66%6.72M26.12%5.99M26.21%20.24M10.82%4.98M
-General and administrative expense -6.51%6.45M-0.48%6.69M29.21%7.74M28.75%26.06M29.66%6.45M35.79%6.9M23.66%6.72M26.12%5.99M26.21%20.24M10.82%4.98M
Research and development costs -50.63%13.34M4.61%22.64M-3.10%24.78M50.56%101M37.58%26.76M62.79%27.02M50.72%21.64M53.41%25.57M17.72%67.08M36.05%19.45M
Operating profit 41.66%-19.79M-3.41%-29.33M-3.03%-32.52M-48.10%-127.06M-35.96%-33.22M-56.47%-33.92M-50.00%-28.36M-51.91%-31.56M-23.97%-85.8M-35.47%-24.43M
Net non-operating interest income expense
Other net income (expense) -46.78%1.36M-45.95%1.67M-12.83%2M424.48%10.26M58.18%2.34M475.17%2.55M1,221.45%3.08M641.42%2.29M39,040.00%1.96M1,309.52%1.48M
Other non- operating income (expenses) -46.78%1.36M-45.95%1.67M-12.83%2M424.48%10.26M58.18%2.34M475.17%2.55M1,221.45%3.08M641.42%2.29M39,040.00%1.96M1,309.52%1.48M
Income before tax 41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M
Income tax
Net income 41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M
Net income continuous Operations 41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M
Minority interest income
Net income attributable to the parent company 41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M
Basic earnings per share 42.68%-0.47-7.58%-0.71-3.95%-0.79-18.22%-3.05-26.56%-0.81-30.16%-0.82-6.45%-0.66-10.14%-0.76-1.98%-2.58-4.92%-0.64
Diluted earnings per share 42.68%-0.47-7.58%-0.71-3.95%-0.79-18.22%-3.05-26.56%-0.81-30.16%-0.82-6.45%-0.66-10.14%-0.76-1.98%-2.58-4.92%-0.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data